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Scratching the surface
The epithelial surface is the site at which we first encounter
pathogens. Two recent advances indicate that intraepithelial
lymphocytes use specialized tools to help protect this surface.
The skin and the digestive, respiratory and genitourinary
tracts are covered by epithelia. Epithelia serve as selective
borders that allow for the orderly transit of water, ions,
gases, nutrients and waste products, but protect against
the entry of pathogens. Epithelial cells thus provide a
critical physical barrier, separating us from our
surroundings. Many epithelia contain specialized T cells
- intraepithelial lymphocytes - which in many cases
derive from different precursors, and have different T-cell
receptor repertoires, than other T cells. Despite these dif-
ferences, intraepithelial lymphocytes behave similarly to
other T cells in many in vitro assays of T-cell function.
Emerging evidence, however, indicates that intra-
epithelial lymphocytes have unique properties that help
them to interact with epithelial cells. In particular, recent
results from several laboratories are beginning to provide
a detailed understanding of two mechanisms that specific.
interactions between intraepithelial lymphocytes and
epithelial cells.
The first important discovery came from a series of
experiments designed to identify and characterize mol-
ecules that might be selectively expressed on the surface
of intraepithelial lymphocytes. In the 1980s, several
groups produced monoclonal antibodies that reacted
with intestinal intraepithelial lymphocytes from various
Fig. 1. Expression of integrin oaE37 and E-cadherin in the human
small intestine. Sections through villi of normal human small
intestine were stained with antibody to (a) yaE37 or (b) E-cad-
herin. EP37 is expressed on lymphocytes in the epithelium and
lamina propria, but not on epithelial cells. E-cadherin is
expressed on the basolateral surface of epithelial cells.
(Photomicrographs courtesy of Michael Brenner and Gary
Russell; reproduced with permission from [9] and [13].)
species. Several of these antibodies, including HML-1
and M290, are now known to recognize the integrin
otE0 7 (also known as cell-surface marker CD103) [1,2].
OLaE7 is expressed on nearly all intestinal intraepithelial
lymphocytes, and on many lymphocytes in the lamina
propria, just below the epithelium (Fig. la); lympho-
cytes within or immediately adjacent to respiratory or
reproductive epithelia also frequently express oLE3 7.
Mouse skin intraepithelial lymphocytes uniformly
express aE3 7 at a high level [3]. These 'dendritic epi-
dermal T cells' derive from a unique thymic precursor,
have an unusual morphology and express a single, essen-
tially invariant y/ T-cell receptor. No such population is
found in the human epidermis, and T cells in the human
dermis do not normally express otaE7. For the most part,
T cells at non-epithelial sites are much less likely to ex-
press this integrin. For example, E[37 is expressed on
only -3-5% of mouse thymocytes and only -1-3% of
human blood T cells. Mast cells, which are abundant in
the vicinity of some epithelia, express atE 3 7 following
activation in vitro [4], but B cells, granulocytes, and non-
leukocytic cells are not known to be capable of expressing
this integrin.
The identification of the HML-1/M290 antigen as a
member of the integrin family provided important clues
about possible functions of this molecule. Integrins are
heterodimeric cell-surface glycoproteins that can mediate
both cell-extracellular matrix and cell-cell adhesion. For
example, the interaction of the lymphocyte integrins
LFA-1 (xaL32) and VLA-4 (4 1 ) with the endothelial
cell ligands intercellular adhesion molecule-1 (ICAM-1)
and vascular cell adhesion molecule-1 (VCAM-1) is
known to be crucial for the recruitment of these cells
from the bloodstream into a variety of tissues. Ligand
binding by integrins is known to involve both their ot
and 3 subunits.
The HML-1/M290 a( subunit, tE, is distinct from all
other previously characterized integrin ot subunits; it is
not known to be capable of pairing with any integrin 13
subunit other than its HML-1/M290 partner, 7.
However, the subunit, 37, is able to associate with
either of two integrin oa subunits: o(E or ao4. This finding
generated considerable interest, as t4 37 has a special role
in directing lymphocyte traffic; at41 7 is a receptor for
MAdCAM-1 (mucosal addressin cell adhesion molecule
1), a glycoprotein selectively expressed on endothelial
cells in the gut and associated lymphoid organs [5]. This
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adhesive interaction directs the selective recruitment
(or 'homing') of a subset of blood T cells expressing high
levels of or4 37 to these sites.
It has long been hypothesized that intraepithelial lympho-
cyte precursors use a homing receptor to migrate selec-
tively to the epithelium. The structural similarity of otE3 7
to other molecules involved in directing lymphocyte
traffic fueled speculation that this integrin might be the
intraepithelial lymphocyte homing receptor. To test this
possibility, several investigators analyzed the effects of anti-
tEP7 antibodies on T-cell-endothelial cell adhesion in
vitro, and on T-cell migration in vivo. The anti-otE3 7 anti-
bodies do not seem to have effects in either system. While
it is possible that these antibodies fail to block because
they recognize epitopes of otEP 7 that are not involved in
binding to the relevant ligand, these results did suggest
that a search for other potential tEP7 ligands was justified.
The first major breakthrough in the search for otE3 7
ligands came from the observation that the adhesion in
vitro of intestinal intraepithelial lymphocytes to epithelial
cells derived from intestine, breast, or lung could be
inhibited by antibodies against aE 37 [6-8]. Cepek and
colleagues [9] have now made the exciting and un-
expected discovery that otEP7-mediated adhesion of
human intraepithelial lymphocytes to epithelium in vitro
is dependent upon the epithelial cell adhesion molecule
E-cadherin (Fig. lb). The evidence for this is as follows.
First, antibodies against E-cadherin inhibit binding of
intraepithelial lymphocytes to the same extent as anti-
bodies against E3 7, and the effects are not additive.
Second, antibodies against E-cadherin have no effect on
binding of lymphocytes that do not express oE[ 37. Third,
binding of intraepithelial lymphocytes to transfected cells
expressing E-cadherin, but not to mock transfectants, is
inhibited by antibodies against otE 7. And fourth, bind-
ing of txE 37-transfected, but not X4$ 7 -transfected, cells
to epithelium is blocked by antibodies to E-cadherin.
Similar results have now been obtained using mouse
intestinal intraepithelial lymphocytes and epithelial cells
[10]. Although these data do not prove a direct inter-
action between OaE3 7 and E-cadherin, they do strongly
suggest that these molecules may be counter-receptors.
This comes as a surprise, as 'classical' E-cadherin-
mediated interactions are both homotypic and homo-
philic: an E-cadherin molecule on the surface of an
epithelial cell acts by binding to another E-cadherin
molecule on the surface of an adjacent epithelial cell
(Fig. 2). (Adhesion of intraepithelial lymphocytes to
epithelial cells cannot be mediated by homophilic E-cad-
herin binding, as intraepithelial lymphocytes do not
express E-cadherin.) The otE 37-E-cadherin interaction is
the first known interaction between members of these
two major families of cell adhesion molecules.
There are at least three possible explanations for the high
frequency of orE[3 7 expression on intraepithelial lympho-
cytes. First, it seems likely that the oE37-E-cadherin
Fig. 2. Adhesive interactions mediated by integrin aE37 and
E-cadherin. Epithelial cell adhesion to adjacent epithelial cells is
mediated by the homophilic interaction of two E-cadherin
molecules. Epithelial cell adhesion to intraepithelial lymphocytes
is mediated by both E-cadherin and aE37 . This is likely to involve
heterophilic binding of UEp 7 to E-cadherin (see text).
interaction acts to favor the retention of T cells express-
ing orE[3 7 in the epithelium. This would provide a mech-
anism for accumulating lymphocytes in specific tissues
that does not depend on 'homing' (a term best reserved
for processes involving organ-specific lymphocyte-
endothelial cell interactions). Second, it is possible that
E 37-expressing intraepithelial lymphocyte precursors
are selectively recruited to epithelia; this possibility is
supported by the recent finding [3] that a subset of
thymic intraepithelial lymphocyte precursors do express
o(E[3 7. However, it is not yet known if thymocyte E[37
expression is restricted to intraepithelial lymphocyte pre-
cursors. (An alternative possibility is that oaE3 7 is required
at a particular stage of thymic differentiation of intra-
epithelial lymphocytes as well as other T cells.) The
selective recruitment of (xE 37-expressing cells could be
mediated by orEI3 7 itself or by another, as yet unidentified
homing receptor. The third possible explanation for the
high frequency of E[37 expression on intraepithelial
lymphocytes is induction in situ. Blood or lymph node T
cells can be induced to express olrE3 7 by exposure to the
growth factor TGF-3, which is produced by epithelial
cells [1]. In addition, it has now been shown that
immunoglobulin-E-mediated activation of mast cells
causes the release of soluble factor(s) that induce oE[37
expression by T cells [4]. The ability of soluble factors to
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induce changes in otaEP 7 expression may allow epithelial
cells and mast cells to exert some control over the
retention of T cells in the epithelium.
Integrins do more than simply promote cell adhesion. It
is now clear that many integrins interact with a variety of
intracellular proteins, including protein tyrosine kinases,
and that engagement of integrins by ligand molecules (or
by anti-integrin antibodies) can trigger signals that lead
to alterations in cell behavior. oaE0 7 is apparently involved
in signaling as well, as antibodies against oE 7 have been
found to stimulate intraepithelial lymphocyte prolifera-
tion and cytolytic activity in vitro [3,11]. These results
suggest that aE P7-mediated binding to E-cadherin or
other potential ligands could influence intraepithelial
lymphocyte proliferation and function in vivo.
A second new discovery helps to illuminate one mecha-
nism that allows certain intraepithelial lymphocytes to
modulate epithelial cell proliferation and function. This
discovery began with the observation that activated
mouse skin intraepithelial lymphocytes produce a soluble
factor that promoted the growth of keratinocytes in
culture [12]. The factor was identified as keratinocyte
growth factor (KGF), known to be required for normal
growth and repair of epidermis. KGF also promotes the
proliferation of epithelial cells other than keratinocytes,,
and further investigation revealed that it is also produced
by intraepithelial lymphocytes from mouse intestine.
Strikingly, KGF was found to be produced only by
intraepithelial lymphocytes expressing the y T-cell
receptor: intraepithelial lymphocytes expressing the at3
T-cell receptor, and non-epithelial T cells expressing
both y and cs3 T-cell receptors, could not produce
KGE After skin wounding, other cells in the dermis are
likely to produce more KGF than do intraepithelial
lymphocytes, but KGF produced by intraepithelial
lymphocytes may be especially important as it is released
directly within the epidermis. In addition, intraepithelial
lymphocytes might produce KGF in response to some
stimuli that fail to induce KGF production by other
cell types.
The discoveries of integrin oLEP 7 and of KGF-producing
intraepithelial lymphocytes are important early steps
toward an understanding of the functional differences
between intraepithelial lymphocytes and other T cells.
These discoveries indicate that intraepithelial lympho-
cytes have specialized mechanisms for communicating
with epithelial cells. It will be important to determine
how these mechanisms contribute to a coordinated
response to infection and wounding of the epithelium.
Valuable insights are likely to come from mouse experi-
ments, such as studies of OaE gene knockout mice, that
directly address the importance of specific mechanisms in
vivo. As there are important cross-species differences in
intraepithelial lymphocyte ontogeny and phenotype,
additional studies will be required to determine how
these insights apply to other species, including humans.
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